---
schema_version: "secwatch.filing_event.v1"
accession: "0001116463-24-000051"
form_type: "8-K"
ticker: "OSUR"
cik: "0001116463"
company_name: "ORASURE TECHNOLOGIES INC"
filed_at: "2024-12-19T23:59:59+00:00"
generated_at: "2026-05-29T01:02:46.710823+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "low"
source: SEC EDGAR
---

# OraSure acquires Sherlock Biosciences; deal terms not disclosed in 8-K filing

## Summary
- OraSure announced acquisition of Sherlock Biosciences on December 19, 2024, but no deal value or financial terms provided.
- The 8-K furnishes an investor presentation (Exhibit 99.1) with only a title slide; no new substantive details were given.
- Acquisition press release referenced as Exhibit 99.2 but full text not included in the filing excerpt.

## SEC filing metadata
- accession: 0001116463-24-000051
- form_type: 8-K
- ticker: OSUR
- cik: 0001116463
- company_name: ORASURE TECHNOLOGIES INC
- filed_at: 2024-12-19T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: low
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1116463/000111646324000051/0001116463-24-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1116463/000111646324000051/osur-20241219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001116463-24-000051
- JSON: https://secwatch.observer/filing/0001116463-24-000051.json
- Plain text: https://secwatch.observer/filing/0001116463-24-000051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.